← Leaderboards
Yuhua Song
Carnegie-Mellon University
$4,661,572
Attributed
$4,661,572
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,661,572 · 5
By mechanism
R01$3,891,369 · 2
K25$768,940 · 1
P41$1,263 · 2
Top collaborators
No co-investigators on record.
Most similar at Carnegie-Mellon University
Same institution · by research overlap
- Weifan Zheng$394,383
- Gordon S. Rule$1,769,855
- Bentley A Strockbine$2,877
- John Beale$2,185
- Miguel Llinas$2,863,716
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAffectMolecular ConformationSignal TransductionMolecularBiologicalMediatingReceptorCellsSiteStructureVariantInsightLigandsLigand BindingRegulationPathogenesisClinical TrialsDockingAmino AcidsCombination Drug TherapyExperimental StudyBiophysicsApolipoprotein E-2
Grant awards (15)
Drugs repositioning to target TREM2 in Alzheimer disease$564,646
R01 · FY2025 · AG · contact PI
TREM2-endogenous ligand interactions in Alzheimer disease$414,919
R01 · FY2025 · AG · contact PI
Drugs repositioning to target TREM2 in Alzheimer disease$587,814
R01 · FY2024 · AG · contact PI
TREM2-endogenous ligand interactions in Alzheimer disease$424,035
R01 · FY2024 · AG · contact PI
Drugs repositioning to target TREM2 in Alzheimer disease$611,134
R01 · FY2023 · AG · contact PI
TREM2-endogenous ligand interactions in Alzheimer disease$424,956
R01 · FY2023 · AG · contact PI
TREM2-endogenous ligand interactions in Alzheimer disease$425,582
R01 · FY2022 · AG · contact PI
TREM2-endogenous ligand interactions in Alzheimer disease$438,283
R01 · FY2021 · AG · contact PI
Protein interactions underlying Fas-mediated DISC in Cholangiocarcinoma$154,060
K25 · FY2013 · CA · contact PI
Protein interactions underlying Fas-mediated DISC in Cholangiocarcinoma$154,060
K25 · FY2012 · CA · contact PI
Protein interactions underlying Fas-mediated DISC in Cholangiocarcinoma$154,060
K25 · FY2011 · CA · contact PI
Protein interactions underlying Fas-mediated DISC in Cholangiocarcinoma$154,060
K25 · FY2010 · CA · contact PI
Protein interactions underlying Fas-mediated DISC in Cholangiocarcinoma$152,700
K25 · FY2009 · CA · contact PI
IN SILICO STUDY OF GLYCOSYLATION EFFECTS ON INTEGRIN STRUCTURE AND FUNCTION$790
P41 · FY2009 · RR · contact PI
IN SILICO STUDY OF GLYCOSYLATION EFFECTS ON INTEGRIN STRUCTURE AND FUNCTION$473
P41 · FY2008 · RR · contact PI